Asha Shaban
【Product name】Eliquis
[English common name]Apixaban
[Chinese common name]Asha Shaban
[English name]
[Chinese other name]
[Indications] Eliquis is used to prevent venous thromboembolism (venous thrombosis) in adults after hip or knee replacement. It is also used for adult treatment of deep vein thrombosis (Deep vein thrombosis, usually in the leg) and pulmonary embolism (a clot in the blood vessels of the blood supply) and prevent it from happening again.
In addition, Eliquis is used to prevent blood clots in other organs of stroke (caused by blood clots in the brain) and adult atrial fibrillation (irregular rapid contraction of the upper chamber of the heart). It is used in patients with one or more risk factors, such as having a stroke, high blood pressure, diabetes, heart failure, or 75 years of age or older.
[Usage and Dosage] For patients with hip or knee replacement, Eliquis should be used.
24 hours after surgery. The recommended dose is a 2.5 mg tablet twice daily, usually one month after the hip replacement (32 to 38 days) or 10 to 14 days after the knee. For patients with atrial fibrillation at risk of stroke or thrombosis, the recommended dose is 5 mg twice daily.
For the treatment of deep vein thrombosis and pulmonary embolism, the recommended dose is 10 mg twice daily for the first week and then twice daily for 5 mg for at least 3 months. To prevent deep vein thrombosis and re-emergence of pulmonary embolism, the recommended dose is 2.5 mg twice daily.
[Storage] Keep this medicine away from the child's sight and range. Do not use this medicine after the expiration date stated on the carton and after the blister on the EXP. The due date is the last day of the month.
This medicine does not require any special storage conditions. Do not discard any drugs through wastewater or household waste. Ask your pharmacist how to discard drugs that you no longer use. These measures will help protect the environment.
[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
name
Attention: The internal data of table “854” is corrupted!
product
product manual
Related products
-
Deep vein thrombosis
Fondaparinux
【Product name】ARIXTRA
[English common name]Fondaparinux Prefilled Syringe
[Chinese common name]Pentosan sodium prefilled injection
[English name]
[Chinese other name]
[Indications] Adults (18 years old or older) used to prevent major surgery on the legs.Venous thromboembolismEvent (VTE, due toVenous thrombosisThe problem caused by the formation), such as hip or knee surgery. It can also be used in high-risk adults (because of their age or illness) when they undergo abdominal surgery or are forced to stay in bed due to acute illness.
[Usage and Dosage] The recommended dose is 2.5mg once a day, subcutaneously (under the skin). For patients undergoing surgery, the first dose should be given 6 hours after the end of surgery. Treatment should continue until the risk of VTE is reduced, usually at least 5 to 9 days after surgery. For patients with kidney problems, Arixtra may not be appropriate or a 1.5 mg dose may be used.
In the treatment of superficial vein thrombosis, the recommended dose is 2.5 mg once a day by subcutaneous injection. Treatment should begin as soon as possible after DVT is excluded and should last for 30 to 45 days.
In the treatment of DVT or PE, the recommended dose is 7.5 mg, once a day subcutaneously, usually 7 days. The dose can be adjusted according to body weight.
For patients with unstable angina or myocardial infarction, the recommended dose is 2.5 mg once daily, subcutaneously, but the first dose is via intravenous injection (intravenous injection) or ST-segment elevation infusion (drip) . Treatment should begin as soon as possible after diagnosis and last up to 8 days or until the patient is discharged.[Storage] shading, sealed, and stored at 25 ° C (do not freeze).
[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
-
Deep vein thrombosis , Pulmonary embolism
Rivaroxaban
【Product name】Xarelto
[English common name]Rivaroxaban
[Chinese common name]Rivaroxaban
[English name]
[Chinese other name]
[indications]
1. For adult patients undergoing elective hip or knee replacement surgery to preventVenous thrombosisForm (VTE).
2. For the treatment of adult venous thrombosis (DVT), reduce DVT recurrence after acute DVT andPulmonary embolism(PE) risk.
3. For adult patients with non-valvular atrial fibrillation with one or more risk factors (eg, congestive heart failure, hypertension, age ≥75 years, diabetes, stroke, or transient ischemic attack), Reduce the risk of stroke and systemic embolism.【Dosage】Rifasanban administration method:oral.
Rivaroxaban 10mg can be taken with food or taken alone.
Rivaroxaban 15mg or 20mg tablets should be taken with food.
Prevention of venous thrombosis in adult patients undergoing elective hip or knee replacement surgery
The recommended dose is oral rivaroxaban 10 mg once daily. If the wound has stopped bleeding, the first time of administration should be between 6 and 10 hours after surgery.
For patients undergoing major hip surgery, the recommended course of treatment is 35 days.
For patients undergoing major knee surgery, the recommended course of treatment is 12 days.
If a missed condition occurs, the patient should take rivaroxaban immediately and continue taking the drug once a day.
Treatment of DVT, reducing the risk of acute DVT recurrence and PE
The initial recommended dose for acute DVT is 15 mg twice daily for the first three weeks, after which the dose to maintain treatment and reduce the risk of recurrence of DVT is 20 mg once daily.[Storage] Sealed at room temperature.
[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
简体中文